Not yet recruiting NCT06758908
Prevelance, Predictors and Outcome of Sepsis Associated Liver Injury (SALI)
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Antibiotic.
- Who it may be relevant to
- Registry conditions: Liver Injuries. Basic parameters: 15 years — 75 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
prevelance, predictors and outcome of sepsis associated liver injury (SALI)
Detailed description
patient with liver disease and sepsis at the same time
Interventions
- Device Antibiotic
SALI
Primary outcome measures
- prevelance, predictors and outcome of sepsis associated liver injury (SALI) [Time frame: baseline]
- 28 days mortality [Time frame: baseline]
- patient shouldn't be in pain [Time frame: baseline]
Secondary outcome measures (1)
- patient stay in hospital 2weeks [Time frame: baseline]
Eligibility criteria
Inclusion criteria
- clinical diagnosis of SALI
- must take liver support
Exclusion criteria
- SALI
- Thyroid disease
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT06758908 · prevelance ,predictors of SALI